Oncology Institute Inc
TOILatest QuantConomy context for TOI: asset profile, market coverage, scored signals, and source-linked SEC insider filings when available.
Oncology Institute Inc
QuantConomy has a structured record for TOI. More descriptive asset metadata will appear here when the platform record includes it.
- Symbol
- TOI
- Name
- Oncology Institute Inc
- Coverage
- 3 market/data records
- Sources
- fmp alpaca alphavantage sec nasdaq tsx
Recent signals for TOI
Scored rows are pulled from the same signal API used by the digests.
| Signal | Direction | Score | Observed | Reason |
|---|---|---|---|---|
| operating income change | bullish | 84 | Jul 11, 12:00 AM | TOI (Q1 2026, operating income): grew 34.3% (-$9.91M → -$6.51M). [year-over-year basis, bullish signal] |
| eps change | very bullish | 95 | Jul 11, 12:00 AM | TOI (Q1 2026, diluted eps): EPS grew 90.5% ($-0.21 → $-0.02). [year-over-year basis, very bullish signal] |
| net income change | very bullish | 95 | Jul 11, 12:00 AM | TOI (Q1 2026, net income): grew 87.3% (-$19.59M → -$2.49M). [year-over-year basis, very bullish signal] |
FUNDAMENTAL signals are experimental: the generator was recently enabled and coverage is still being validated.
PRICE signals are experimental: realized 30-day directional accuracy is ~18% (short-horizon price moves tend to mean-revert). They are automatically down-weighted in composite scores but served raw here. Do not use them as standalone trade advice.
Market coverage
| Market | Exchange | Source | Asset record |
|---|---|---|---|
| TOI | NASDAQ | fmp | The Oncology Institute, Inc. |
| TOI | NASDAQ | alpaca | The Oncology Institute, Inc. Common Stock |
| TOI | NASDAQ | alphavantage | Oncology Institute Inc (The) |
Recent insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jul 7, 2026 | TZOUMAKAS KIMBERLY JO | Insider | grant | 17,185 | $0.00 | $0 | 4 on EDGAR |
| Jul 7, 2026 | STOLPER MARK | Insider | grant | 25,833 | $0.00 | $0 | 4 on EDGAR |
| Jun 23, 2026 | Chernett Jorey | Insider | purchase | 18,000 | $5.02 | $90,360 | 4 on EDGAR |
| Jun 8, 2026 | Podnos Yale | Chief Medical Officer | sale | 23,451 | $5.38 | $126,094 | 4 on EDGAR |
| Jun 4, 2026 | Chernett Jorey | Insider | purchase | 12,000 | $4.75 | $57,000 | 4 on EDGAR |
| May 21, 2026 | Virnich Daniel | Chief Executive Officer | other | 23,058 | $4.47 | $103,069 | 4 on EDGAR |
| May 21, 2026 | Carter Robert Ross | Chief Financial Officer | other | 1,604 | $4.47 | $7,170 | 4 on EDGAR |
| May 21, 2026 | Podnos Yale | Chief Medical Officer | other | 1,805 | $4.47 | $8,068 | 4 on EDGAR |
| May 19, 2026 | Chernett Jorey | Insider | purchase | 5,000 | $4.05 | $20,250 | 4 on EDGAR |
| May 19, 2026 | Chernett Jorey | Insider | purchase | 30,000 | $4.09 | $122,700 | 4 on EDGAR |
| Apr 14, 2026 | Kaushal Mohit | Insider | sale | 57,286 | $3.50 | $200,598 | 4 on EDGAR |
| Apr 9, 2026 | Chernett Jorey | Insider | purchase | 20,000 | $3.10 | $62,000 | 4 on EDGAR |
| Mar 27, 2026 | Carter Robert Ross | Chief Financial Officer | grant | 202,914 | $0.00 | $0 | 4 on EDGAR |
| Mar 27, 2026 | Langsam Jeffrey | Chief Clinical Officer | grant | 70,270 | $0.00 | $0 | 4 on EDGAR |
| Mar 27, 2026 | Podnos Yale | Chief Medical Officer | grant | 66,446 | $0.00 | $0 | 4 on EDGAR |
| Mar 27, 2026 | Virnich Daniel | Chief Executive Officer | grant | 670,608 | $0.00 | $0 | 4 on EDGAR |
| Mar 27, 2026 | Chernett Jorey | Insider | purchase | 27,429 | $2.96 | $81,190 | 4 on EDGAR |
| Mar 27, 2026 | England Kristin | Chief Administrative Officer | grant | 55,743 | $0.00 | $0 | 4 on EDGAR |
Source: SEC filings via QuantConomy. Not investment advice.
Query TOI context like a database.
These rows come from the QuantConomy signal, asset, market, and SEC filings API surfaces, also available to AI agents over MCP.
More: All insider trades · How to read a Form 4 · API access